These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 14963667

  • 1. Natriuretic peptides and myocardial ischaemia.
    Baxter GF.
    Basic Res Cardiol; 2004 Mar; 99(2):90-3. PubMed ID: 14963667
    [Abstract] [Full Text] [Related]

  • 2. Acute actions of natriuretic peptides in coronary vasculature and ischaemic myocardium.
    Rautureau Y, Baxter GF.
    Curr Pharm Des; 2004 Mar; 10(20):2477-82. PubMed ID: 15320757
    [Abstract] [Full Text] [Related]

  • 3. Autocrine and paracrine actions of natriuretic peptides in the heart.
    D'Souza SP, Davis M, Baxter GF.
    Pharmacol Ther; 2004 Feb; 101(2):113-29. PubMed ID: 14761702
    [Abstract] [Full Text] [Related]

  • 4. B-type natriuretic peptide at early reperfusion limits infarct size in the rat isolated heart.
    Burley DS, Baxter GF.
    Basic Res Cardiol; 2007 Nov; 102(6):529-41. PubMed ID: 17896117
    [Abstract] [Full Text] [Related]

  • 5. Natriuretic peptides as therapy in cardiac ischaemia/reperfusion.
    Kousholt BS.
    Dan Med J; 2012 Jun; 59(6):B4469. PubMed ID: 22677252
    [Abstract] [Full Text] [Related]

  • 6. The natriuretic peptides.
    Baxter GF.
    Basic Res Cardiol; 2004 Mar; 99(2):71-5. PubMed ID: 14963664
    [Abstract] [Full Text] [Related]

  • 7. Effect of atrial natriuretic peptide on left ventricular remodelling in patients with acute myocardial infarction.
    Kasama S, Furuya M, Toyama T, Ichikawa S, Kurabayashi M.
    Eur Heart J; 2008 Jun; 29(12):1485-94. PubMed ID: 18490430
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The role of natriuretic peptides in cardioprotection.
    Nishikimi T, Maeda N, Matsuoka H.
    Cardiovasc Res; 2006 Feb 01; 69(2):318-28. PubMed ID: 16289003
    [Abstract] [Full Text] [Related]

  • 11. A strategy of retrograde injection of bone marrow mononuclear cells into the myocardium for the treatment of ischemic heart disease.
    Yokoyama S, Fukuda N, Li Y, Hagikura K, Takayama T, Kunimoto S, Honye J, Saito S, Wada M, Satomi A, Kato M, Mugishima H, Kusumi Y, Mitsumata M, Murohara T.
    J Mol Cell Cardiol; 2006 Jan 01; 40(1):24-34. PubMed ID: 16271723
    [Abstract] [Full Text] [Related]

  • 12. Myocardial protection against reperfusion injury: the cGMP pathway.
    Garcia-Dorado D, Agulló L, Sartorio CL, Ruiz-Meana M.
    Thromb Haemost; 2009 Apr 01; 101(4):635-42. PubMed ID: 19350105
    [Abstract] [Full Text] [Related]

  • 13. A potential role for angiotensin II in obesity induced cardiac hypertrophy and ischaemic/reperfusion injury.
    du Toit EF, Nabben M, Lochner A.
    Basic Res Cardiol; 2005 Jul 01; 100(4):346-54. PubMed ID: 15821998
    [Abstract] [Full Text] [Related]

  • 14. [Brain natriuretic peptide in acute coronary syndromes: utility of NT-pro BNP assay].
    Ollivier JP, Revel F.
    Bull Acad Natl Med; 2004 Jul 01; 188(9):1529-38; discussion 1538-40. PubMed ID: 15997622
    [Abstract] [Full Text] [Related]

  • 15. Pregnancy alters nitric oxide synthase and natriuretic peptide systems in the rat left ventricle.
    Jankowski M, Wang D, Mukaddam-Daher S, Gutkowska J.
    J Endocrinol; 2005 Jan 01; 184(1):209-17. PubMed ID: 15642797
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of ischaemic preconditioning in the eNOS overexpressed working mouse heart model.
    du Toit EF, Genade S, Carlini S, Moolman JA, Brunner F, Lochner A.
    Eur J Pharmacol; 2007 Feb 05; 556(1-3):115-20. PubMed ID: 17157294
    [Abstract] [Full Text] [Related]

  • 17. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.
    Ferdinandy P, Schulz R, Baxter GF.
    Pharmacol Rev; 2007 Dec 05; 59(4):418-58. PubMed ID: 18048761
    [Abstract] [Full Text] [Related]

  • 18. Signalling pathways in ischaemic postconditioning.
    Hausenloy DJ.
    Thromb Haemost; 2009 Apr 05; 101(4):626-34. PubMed ID: 19350104
    [Abstract] [Full Text] [Related]

  • 19. Cardioprotective actions of peptide hormones in myocardial ischemia.
    Burley DS, Hamid SA, Baxter GF.
    Heart Fail Rev; 2007 Dec 05; 12(3-4):279-91. PubMed ID: 17516166
    [Abstract] [Full Text] [Related]

  • 20. Mast cells, peptides and cardioprotection - an unlikely marriage?
    Walsh SK, Kane KA, Wainwright CL.
    Auton Autacoid Pharmacol; 2009 Jul 05; 29(3):73-84. PubMed ID: 19566747
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.